Sort by
Refine Your Search
-
Listed
-
Category
-
Program
-
Field
-
Treatment Clinic. WORK SCHEDULE: • Full-time, 100% FTE, 40 hours per week • Mon - Fri 8:00a-4:30p (open to four 10's after orientation) POSITION HIGHLIGHTS: • Conveniently located near public
-
, intellectual excitement, artistic pursuits and natural beauty. The University of Washington’s Information School is seeking a MLIS/PhD Program Coordinator to provide primary support to the Information School's
-
Scheduled Hours 37.5 Position Summary Within the Center for Career Engagement, the Associate Director, Career & Professional Development for PhD & Postdoctoral Scholars uniquely understands
-
channels for the treatment of cardiac arrhythmias. Duties include experiment design, data collection and analysis, documentation of experiment results, writing manuscripts, assisting in writing research
-
. Assessment and treatment procedures at the clinic must meet a uniformly high standard in terms of empirical validity and must be compatible with the clinical science model of training in clinical psychology
-
and treatment procedures at the clinic must meet a uniformly high standard in terms of empirical validity and must be compatible with the clinical science model of training in clinical psychology
-
research portfolio totals $67 million in grants and contracts per year for projects ranging from clinical neurosciences to treatment development to health policy and population health. The Department is
-
target validation: cell culture/primary cell culture and functional assays (drug treatment, proliferation, invasion, angiogenesis, etc), transfection, CRISPR, flow cytometry, Western Blot, DNA/RNA
-
therapy approaches. We are seeking a postdoctoral researcher interested in working on genetically modified hematopoietic stem cells and chimeric antigen receptor (CAR) T cells for treatment of hematologic
-
research team led by Dr. Hofstetter, a renowned academic neurosurgeon at the University of Washington. Our team is at the forefront of developing groundbreaking biomarkers and experimental treatment